Related Experiment Video
Updated: Aug 8, 2025

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
Peripheral neuropathy as clinical onset of monoclonal IgM/k-related amyloidosis
Chiara Briani1, Sergio Ferrari2, Tamara Berno3
1Department of Neurosciences, University of Padova, Padova, Italy.
Aim:
Neuropathy is a frequent complication of Waldenström's macroglobulinemia (WM), the most common being a demyelinating polyneuropathy with anti-myelin associated glycoprotein (MAG) antibodies, but also cryoglobulins, vasculitis, neurolymphomatosis, and amyloidosis. We describe a patient with IgM/kappa WM who presented with a severe, not length-dependent, peripheral neuropathy as clinical onset of IgM/kappa-related amyloidosis.
Methods:
A 69-year-old woman came to our attention for weight loss, gait imbalance and sensory loss at upper limbs. In her medical history, she was in hematological follow-up for WM, and had undergone left carpal tunnel release. At neurological evaluation she had weakness and loss of sensation at upper limbs up to the elbows, more at the left side, gait was unsteady with right foot drop. Hypotrophy and areflexia were present at four limbs. Sensory loss and vibration sense were dramatically reduced. She underwent extensive diagnostic workup.
Results:
Laboratory workup revealed an IgM/kappa monoclonal paraprotein of 16 g/L and increased NT-proBNP; anti-MAG antibodies were absent. Bone marrow biopsy demonstrated a population of neoplastic B-lymphocytes. Total-body CT scan and echocardiogram were negative. Neurophysiology revealed a symmetric, no length dependent sensory-motor polyneuropathy Periumbilical fat biopsy was positive for amyloid. Sural nerve biopsy detected amyloid in the wall of an epineurial vein.
Conclusions:
This case report describes a rare and unusual manifestation of IgM-related AL amyloidosis in WM. The patient presented with a subacute clinically asymmetric neuropathy with no pain or dysautonomic features as clinical onset of IgM/kappa-related amyloidosis. Sural nerve biopsy was crucial for the diagnosis.
Insights
Waldenström's macroglobulinemia (WM) can cause neuropathy. This case highlights a rare presentation of IgM-related amyloidosis causing severe, asymmetric neuropathy, diagnosed via sural nerve biopsy.
Area of Science:
- Neurology
- Hematology
- Oncology
Background:
- Waldenström's macroglobulinemia (WM) is often associated with neuropathy.
- Common WM-related neuropathies include demyelinating polyneuropathy with anti-myelin associated glycoprotein (MAG) antibodies, cryoglobulinemia, vasculitis, neurolymphomatosis, and amyloidosis.
Observation:
- A 69-year-old woman with IgM/kappa WM presented with weight loss, gait imbalance, and sensory loss.
- Neurological examination revealed asymmetric weakness and sensory loss in the upper limbs, unsteady gait with foot drop, hypotrophy, and areflexia.
- Diagnostic workup showed an IgM/kappa monoclonal paraprotein, but absent anti-MAG antibodies.
Findings:
- Neurophysiology confirmed a symmetric, non-length-dependent sensory-motor polyneuropathy.
- Periumbilical fat and sural nerve biopsies were positive for amyloid, specifically in the wall of an epineurial vein.
- The patient's neuropathy was identified as a rare manifestation of IgM/kappa-related AL amyloidosis.
Implications:
- This case underscores the importance of considering amyloidosis in WM patients presenting with unusual neuropathy.
- Sural nerve biopsy is a critical diagnostic tool for identifying amyloid deposition in the peripheral nerves.
- Early diagnosis and appropriate management of WM-related amyloidosis are crucial for patient outcomes.
More Related Videos
07:30A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Chronic Kidney Disease II: Clinical Manifestations
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Nephrotic Syndrome I : Introduction
Peripheral Artery Disease I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests